KRISFED Tablet Ref.[115645] Active ingredients: Chlorphenamine

Source: Registered Drug Product Database (NG)  Publisher: Krishat Pharma Industries Limited, KM 15, Lagos-Ibadan Expressway, Ibadan, Oyo State, NIGERIA, Email: info@krishatpharma.com, Company contacts details, operations@krishatpharma.com

4.1. Therapeutic indications

KRISFED Tablets are indicated for the symptomatic relief of:

  • Allergic conditions, including rhinitis, conjunctivitis, and urticaria.
  • Hay fever and perennial allergic rhinitis.
  • Pruritic skin conditions such as eczema, dermatitis, and insect bites.

4.2. Posology and method of administration

Adults and children over 12 years

4 mg (1 tablet) every 4 to 6 hours.

Maximum daily dose: 24 mg (6 tablets).

Children (6-12 years)

2 mg (half a tablet) every 4 to 6 hours.

Maximum daily dose: 12 mg.

Children under 6 years

Not recommended.

Elderly

Use with caution. Start with the lowest effective dose.

Route of administration

Oral, with or without food.

4.9. Overdose

Symptoms

Drowsiness, ataxia, dry mouth, respiratory depression, and convulsions.

Management

Supportive care and symptomatic treatment. Activated charcoal may reduce absorption if given early.

6.3. Shelf life

3 years.

6.4. Special precautions for storage

Store in a cool, dry & dark place below 30°C.

Keep out of reach of children.

6.5. Nature and contents of container

KRISFED Tablets are available in strips packs of 10 tablets.

Pack size: 10x10 tablets.

6.6. Special precautions for disposal and other handling

No special requirements. Dispose of in accordance with local regulations.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.